Gland Pharma Limited Depreciation And Amortization for the year ending March 31, 2025: USD 44.22 M

Gland Pharma Limited Depreciation And Amortization is USD 44.22 M for the year ending March 31, 2025, a 7.04% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.
  • Gland Pharma Limited Depreciation And Amortization for the year ending March 31, 2024 was USD 41.31 M, a 131.38% change year over year.
  • Gland Pharma Limited Depreciation And Amortization for the year ending March 31, 2023 was USD 17.85 M, a 22.91% change year over year.
  • Gland Pharma Limited Depreciation And Amortization for the year ending March 31, 2022 was USD 14.53 M, a 7.68% change year over year.
  • Gland Pharma Limited Depreciation And Amortization for the year ending March 31, 2021 was USD 13.49 M, a 7.48% change year over year.
Key Data
Date Depreciation And Amortization Dividends Paid Common Stock Issued Common Stock Repurchased